Recent Finacing
Recent Raise
Sparrow Pharmaceuticals is a Portland-based cardiometabolic therapeutics company developing clofutriben, an HSD-1 inhibitor for type 2 diabetes patients with elevated cortisol.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Sparrow Pharmaceuticals.
